|
1
|
Han JS and Crowe DL: Tumor initiating
cancer stem cells from human breast cancer cell lines. Int J Oncol.
34:1449–1453. 2009.PubMed/NCBI
|
|
2
|
Gudjonsson T, Villadsen R, Nielsen HL,
Rønnov-Jessen L, Bissell MJ and Petersen OW: Isolation,
immortalization, and characterization of a human breast epithelial
cell line with stem cell properties. Genes Dev. 16:693–706. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vesuna F, Lisok A, Kimble B and Raman V:
Twist modulates breast cancer stem cells by transcriptional
regulation of CD24 expression. Neoplasia. 11:1318–1328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang X, Zheng P, Tang J and Liu Y: CD24:
from A to Z. Cell Mol Immunol. 7:100–103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sleeman KE, Kendrick H, Ashworth A, Isacke
CM and Smalley MJ: CD24 staining of mouse mammary gland cells
defines luminal epithelial, myoepithelial/basal and non-epithelial
cells. Breast Cancer Res. 8:R72006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fogel M, Friederichs J, Zeller Y, Husar M,
Smirnov A, Roitman L, Altevogt P and Sthoeger ZM: CD24 is a marker
for human breast carcinoma. Cancer Lett. 143:87–94. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kristiansen G, Winzer KJ, Mayordomo E,
Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P,
Guski H, et al: CD24 expression is a new prognostic marker in
breast cancer. Clin Cancer Res. 9:4906–4913. 2003.PubMed/NCBI
|
|
8
|
Lim SC: CD24 and human carcinoma: Tumor
biological aspects. Biomed Pharmacother. 59 Suppl 2:S351–S354.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as cancer stem cell markers: An enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponta H, Sherman L and Herrlich PA: CD44:
From adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orian-Rousseau V: CD44, a therapeutic
target for metastasising tumours. Eur J Cancer. 46:1271–1277. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marhaba R and Zöller M: CD44 in cancer
progression: Adhesion, migration and growth regulation. J Mol
Histol. 35:211–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Günthert U, Hofmann M, Rudy W, Reber S,
Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P:
A new variant of glycoprotein CD44 confers metastatic potential to
rat carcinoma cells. Cell. 65:13–24. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kristiansen G, Sammar M and Altevogt P:
Tumour biological aspects of CD24, a mucin-like adhesion molecule.
J Mol Histol. 35:255–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Kim SH, Lee ES and Kim YS: CD24
overexpression in cancer development and progression: A
meta-analysis. Oncol Rep. 22:1149–1156. 2009.PubMed/NCBI
|
|
17
|
Kristiansen G, Machado E, Bretz N, Rupp C,
Winzer KJ, König AK, Moldenhauer G, Marmé F, Costa J and Altevogt
P: Molecular and clinical dissection of CD24 antibody specificity
by a comprehensive comparative analysis. Lab Invest. 90:1102–1116.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Darwish NS, Kim MA, Chang MS, Lee HS, Lee
BL, Kim YI and Kim WH: Prognostic significance of CD24 expression
in gastric carcinoma. Cancer Res Treat. 36:298–302. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ,
Kang SY and Ahn G: Cytoplasmic CD24 expression in advanced ovarian
serous borderline tumors. Gynecol Oncol. 97:379–386. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smith SC, Oxford G, Wu Z, Nitz MD, Conaway
M, Frierson HF, Hampton G and Theodorescu D: The
metastasis-associated gene CD24 is regulated by Ral GTPase
and is a mediator of cell proliferation and survival in human
cancer. Cancer Res. 66:1917–1922. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bretz N, Noske A, Keller S, Erbe-Hofmann
N, Schlange T, Salnikov AV, Moldenhauer G, Kristiansen G and
Altevogt P: CD24 promotes tumor cell invasion by suppressing tissue
factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
Clin Exp Metastasis. 29:27–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baumann P, Cremers N, Kroese F, Orend G,
Chiquet-Ehrismann R, Uede T, Yagita H and Sleeman JP: CD24
expression causes the acquisition of multiple cellular properties
associated with tumor growth and metastasis. Cancer Res.
65:10783–10793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aggarwal BB, Sundaram C, Malani N and
Ichikawa H: Curcumin: The Indian solid gold. Adv Exp Med Biol.
595:1–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Labbozzetta M, Notarbartolo M, Poma P,
Maurici A, Inguglia L, Marchetti P, Rizzi M, Baruchello R, Simoni D
and D'Alessandro N: Curcumin as a possible lead compound against
hormone-independent, multidrug-resistant breast cancer. Ann NY Acad
Sci. 1155:278–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Calaf GM and Hei TK: Establishment of a
radiation- and estrogen-induced breast cancer model.
Carcinogenesis. 21:769–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: WHO Classification of Tumors of the Breast.
4. 4th edition. International Agency for Research on Cancer; Lyon,
France: 2012
|
|
27
|
Dontu G, Al-Hajj M, Abdallah WM, Clarke MF
and Wicha MS: Stem cells in normal breast development and breast
cancer. Cell Prolif. 36 Suppl 1:59–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dontu G, El-Ashry D and Wicha MS: Breast
cancer, stem/progenitor cells and the estrogen receptor. Trends
Endocrinol Metab. 15:193–197. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kordon EC and Smith GH: An entire
functional mammary gland may comprise the progeny from a single
cell. Development. 125:1921–1930. 1998.PubMed/NCBI
|
|
30
|
Ricardo S, Vieira AF, Gerhard R, Leitão D,
Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes
J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression
distribution within intrinsic molecular subtype. J Clin Pathol.
64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou L, Jiang Y, Yan T, Di G, Shen Z, Shao
Z and Lu J: The prognostic role of cancer stem cells in breast
cancer: A meta-analysis of published literatures. Breast Cancer Res
Treat. 122:795–801. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sheridan C, Kishimoto H, Fuchs RK,
Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S and
Nakshatri H: CD44+/CD24− breast cancer cells
exhibit enhanced invasive properties: An early step necessary for
metastasis. Breast Cancer Res. 8:R592006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Honeth G, Bendahl PO, Ringnér M, Saal LH,
Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A and
Hegardt C: The CD44+/CD24− phenotype Is
enriched in basal-like breast tumors. Breast Cancer Res.
10:R532008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mylona E, Giannopoulou I, Fasomytakis E,
Nomikos A, Magkou C, Bakarakos P and Nakopoulou L: The
clinicopathologic and prognostic significance of
CD44+/CD24−/low and
CD44−/CD24+ tumor cells in invasive breast
carcinomas. Hum Pathol. 39:1096–1102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Croker AK, Goodale D, Chu J, Postenka C,
Hedley BD, Hess DA and Allan AL: High aldehyde dehydrogenase and
expression of cancer stem cell markers selects for breast cancer
cells with enhanced malignant and metastatic ability. J Cell Mol
Med. 13:2236–2252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meyer MJ, Fleming JM, Ali MA, Pesesky MW,
Ginsburg E and Vonderhaar BK: Dynamic regulation of CD24 and the
invasive, CD44posCD24neg phenotype In breast
cancer cell lines. Breast Cancer Res. 11:R822009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
